Primo 100 pennarelli per tessutiTry our new method to quickly authenticate your product using the 2D barcode. Click the respective link to download the QR Reader app for your phone. All information contained within this website or in any literature provided is not a prescription to use. Please seek the advice of primo 100 pennarelli physician specializing in Andrology primo 100 pennarelli use. Primo contains methenolone enanthate, a primo 100 pennarelli methenolone ester producing a peimo onset of hormone boosters side effects methenolone with a continued duration of action of 5 to 7 days after IM injection. Ptimo is moderately anabolic with limited androgenic properties.
ghid-supraveghere.info - Primo pennarelli per tessuti
Try our new method to quickly authenticate your product using the 2D barcode. Click the respective link to download the QR Reader app for your phone. All information contained within this website or in any literature provided is not a prescription to use.
Please seek the advice of a physician specializing in Andrology before use. Primo contains methenolone enanthate, a long-acting methenolone ester producing a rapid onset of serum methenolone with a continued duration of action of 5 to 7 days after IM injection. Primo is moderately anabolic with limited androgenic properties. Methenolone cannot aromatize to estrogen, reducing estrogenic side effects, and has a favorable safety profile among anabolic agents. Certain clinical effects and adverse reactions demonstrate the androgenic properties of these drugs.
Complete dissociation of anabolic and androgenic effects has not been achieved. The actions of anabolic steroids are thus similar to those of male sex hormones. Anabolic steroids suppress the gonadotropic functions of the pituitary and may exert a direct effect upon the testes. During exogenous administration of anabolic androgens, endogenous testosterone release is inhibited through inhibition of pituitary luteinizing hormone LH. At large doses, spermatogenesis may be suppressed through feedback inhibition of pituitary follicle-stimulating hormone FSH.
Methenolone is a dihydrotestosterone derivative which cannot be aromatized to estrogen and which acts upon the androgen receptor stimulating anabolism through increased nitrogen retention and protein synthesis in muscle tissue.
Methenolone enanthate in a single dose pharmacokinetic study has demonstrated a mean elimination half-life of 6 days. To compensate for protein catabolism consequent to corticosteroid therapy. Gynecomastia, increased frequency of erections, azospermia, priapism, oligospermia, prostatic hypertrophy,increased risk of prostate carcinoma.
Hirsutism, pattern baldness and acne, gynecomastia. Retention of sodium, chloride, water, potassium, calcium, and inorganic phosphates. Nausea, cholestatic jaundice, alterations in liver function tests; rarely, hepatocellular neoplasms, peliosis hepatitis, hepatic adenomas, and cholestatic hepatitis. Increased or decreased libido, headache, anxiety, depression, and generalized paresthesia. Reduced glucose tolerance and inhibition of gonadotrophin secretion.
Serum lipid changes, hypercalcaemia, hypertension, oedema, and potentiation of sleep apnea. Patients with diagnosed or suspected female breast carcinoma with hypercalcemia as androgenic agents may increase osteolytic bone resorption. Women who are pregnant or may become pregnant because of possible masculinization of the fetus.
Patients with nephrosis or the nephrotic phase of nephritis. Hypersensitivity to this product or any of its ingredients. Discontinue treatment upon signs of jaundicing or hepatotoxicity. Patients on oral anticoagulant therapy require close monitoring especially when androgens are started or stopped.
Periodic evaluations of the prostate should continue while on androgen therapy, especially in patients with difficulty in urination or with changes in voiding habits. Patients on anticoagulants should be carefully monitored during anabolic steroid therapy as anabolic steroids may increase sensitivity to oral anticoagulants.
Patients should be monitored regularly during anabolic steroid therapy, particularly during initiation and termination of therapy. Methenolone Enanthate mg Oil base q. C 20 H 30 O 2 Molecular Weight: Primo is a dihydrotestosterone derived anabolic steroid. Anabolic steroids are synthetic derivatives of testosterone.
Patients with diagnosed or suspected carcinoma of the prostate, breast, or testis. Because androgens may alter serum cholesterol concentration, caution should be used when administering these drugs to patients with a history of myocardial infarction or coronary artery disease. Magnum Pharmaceuticals Authentication Try our new method to quickly authenticate your product using the 2D barcode. Distributors must submit licensing, a company profile, and our completed distributor application for approval prior to ordering.